MHRA

A drug used to treat sleep disorders carries a risk of birth defects when taken in pregnancy.  

The MHRA has asked pharmacists for views on the possible risks associated with the acne medicine isotretinoin.

A criminal network that was behind the illegal online sale of medicines in the UK has been stopped.

An unlicensed flu vaccine used in the US for the past three winters has been granted temporary authorisation for the UK.

Pharmacos that submit applications to some or all of participating countries will have products evaluated in those countries simultaneously

The MHRA has recalled some batches of Metoprolol 50mg tablets.

The MHRA has recalled batches of Epilim 500mg gastro-resistant tablets.

MHRA warns that acute illness may exaggerate effect of warfarin tablets and necessitate dose reduction.

The MHRA is asking healthcare professionals to give patients “stronger warnings” on the risks of opioids.

Six parallel distributors involved in recall of batches of Neupro 4mg/24 hour patches and Vimpat 100mg tablets

The Medicines and Healthcare products Regulatory Agency has published a medicines recall for Amlodipine 10mg tablets.

Monitoring blood concentrations of clozapine for toxicity is now advised in certain clinical situations says MHRA.

Priadel 200mg and 400mg modified release tablets are to be discontinued, with all remaining supplies expected to run out by April of next year. 

Smaller packs, new labelling to warn products do not help with weight loss, and sales restricted to people over 18.

None of 11 tests looked at for REACT-2 meet MHRA criteria for individual home use.

Pharmacists have been told to stop supplying a particular batch of syringes because of a labelling error.

A series of arrests have been made in West Yorkshire after sweets distributed in the area contained cannabis oil.

Companies providing Covid-19 antibody testing services involving fingerprick blood samples have been asked to put the service on hold.

Pfizer is recalling two batches of its oestrogen replacement product Duavive due to concerns around faulty packaging, the MHRA has said.

The MHRA has said it supports the use of the unlicensed anti-viral remdesivir in some Covid-19 patients with “high unmet medical need”.